Serial CEO Buyer Against the Tape
Leon Moulder just dropped $1.01 million on ZBIO shares at $16.88. This marks his 9th purchase in the past year, showing consistent conviction even as the stock trades in confirmed selling pressure across all timeframes. The RSI at 36 suggests oversold conditions, but insiders on this name have struggled lately with only a 23% win rate at 90 days. Healthcare is showing signs of recovery after policy uncertainty, but this CEO is betting against some ugly technicals.
The Filing
| Ticker | ZBIO |
| Company | Zenas BioPharma, Inc. |
| Insider | Leon Moulder Jr, Chief Executive Officer |
| Buy amount | $1.0M |
| Filing date | May 18, 2026 |
| Conviction | Favorable · 66/100 |
| Setup type | Oversold Bounce |
Ultimate members received this analysis in real time.